CN1135892A - New use of Lumbricus extract for treating female genital tract inflammation - Google Patents
New use of Lumbricus extract for treating female genital tract inflammation Download PDFInfo
- Publication number
- CN1135892A CN1135892A CN95110774A CN95110774A CN1135892A CN 1135892 A CN1135892 A CN 1135892A CN 95110774 A CN95110774 A CN 95110774A CN 95110774 A CN95110774 A CN 95110774A CN 1135892 A CN1135892 A CN 1135892A
- Authority
- CN
- China
- Prior art keywords
- extract
- female genital
- lumbricus
- raw material
- earth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000284 extract Substances 0.000 title claims abstract description 23
- 241000243684 Lumbricus Species 0.000 title claims description 21
- 206010058821 Genital tract inflammation Diseases 0.000 title abstract 2
- 210000005002 female reproductive tract Anatomy 0.000 title abstract 2
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 36
- -1 pellicle Substances 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims description 27
- 206010061218 Inflammation Diseases 0.000 claims description 14
- 210000004392 genitalia Anatomy 0.000 claims description 14
- 230000004054 inflammatory process Effects 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 claims description 4
- 235000001014 amino acid Nutrition 0.000 claims description 4
- 102000015636 Oligopeptides Human genes 0.000 claims description 3
- 108010038807 Oligopeptides Proteins 0.000 claims description 3
- 108010023197 Streptokinase Proteins 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 235000018102 proteins Nutrition 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 229960005202 streptokinase Drugs 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 229940088598 enzyme Drugs 0.000 claims description 2
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- 239000000469 ethanolic extract Substances 0.000 claims 1
- 239000002075 main ingredient Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 19
- 230000003628 erosive effect Effects 0.000 abstract description 5
- 239000000829 suppository Substances 0.000 abstract description 2
- 206010046914 Vaginal infection Diseases 0.000 abstract 1
- 201000008100 Vaginitis Diseases 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 238000002481 ethanol extraction Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000003809 water extraction Methods 0.000 abstract 1
- 238000011084 recovery Methods 0.000 description 12
- 239000003814 drug Substances 0.000 description 6
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 241001614060 Amynthas aspergillus Species 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 241000243679 Lumbricidae Species 0.000 description 2
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001088 anti-asthma Effects 0.000 description 2
- 230000001387 anti-histamine Effects 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000001384 succinic acid Substances 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000016908 Female Genital disease Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000237637 Megascolecidae Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000237636 Pheretima Species 0.000 description 1
- 102000013566 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a new application of earthworm extract (water extraction or ethanol extraction) in the aspect of treating female genital tract inflammation. The extract is suitable for external use, and can be made into suppository, pellicle, tablet, effervescent, drop, etc. for treating cervical erosion, vaginitis, etc. The extract has unique therapeutic effect and less adverse side effects.
Description
Technical field
The present invention relates to earth-worm extractive as raw material, promptly Lumbricus water extract or Lumbricus alcohol extract are in the new purposes of treatment female genital inflammation.
Background technology
Lumbricus is medicinal, is listed in the low-grades medicine in Shennong's Herbal, is a suppressing the hyperactive liver to relieve the wind syndrome Chinese medicine.It can heat clearing away, suppressing the hyperactive liver, Zhichuan, collateral dredging.It is fanatical dry to cure mainly height, diseases such as convulsion with spasms, headache due to pathogenic wind-heat.Use the history in existing more than 2,000 year.
There is Lumbricus kind more than 2400 in the known whole world, kind surplus China has 140 approximately.Wherein medicinal Lumbricus has 9 kinds, is subordinate to 2 kinds (huge earthworm section and Lumbricidaes) 3 and belongs to.The medicinal Lumbricus of China mostly is the dry body of huge earthworm section (Megascolecidae) animal Pheretima aspergillum (Pheretgimaaspergillum EPerrier 1872) or the dark different lip earthworm of Lumbricidae (Lumoricidae) animal back (Allolobophora caliginosa trapezoides) (Allolobophora Caliginosa (Savigny) trapezoides Ant, Duges, 1828).Pheretima aspergillum has another name called " LUMBRICUS " (Lumbricus Kwang Tangensis), mainly is distributed in Guangdong, Guangxi, Fujian and the Taiwan of China.Allolobophora caliginosa trapezoides claims " Pheretima " again, almost spreads all over all parts of the country.
The chemical constituent of Lumbricus, the research report is more detailed.According to the literature, Lumbricus chemical constituent alcohol extract contains compositions such as lumbrifebrine, lumbricin, terrestro-lumbrolysin, purine, choline, hypoxanthine, succinic acid, aminoacid, plurality of enzymes, guanidine.The water extract main component is the acid protein of streptokinase, water solublity, PAF, mostly is oligopeptide etc. after the hydrolysis.
The main pharmacological of Lumbricus, modern age, pharmacological evaluation and clinical observation all confirmed:
1, hypotensive effect: the Lumbricus alcohol extract does not have the discovery harmful effect to the heart, brain, liver, kidney, hemopoietic system, endocrine dysfunction.
2, antiasthmatic effect: compositions such as hypoxanthine, succinum alkali, several amino acids to expansion bronchus and antihistaminic allergy, have calmness, antiasthmatic effect.The property of medicine is lasting gently, and curative effect is more than 73%.
3, refrigeration function: lumbrifebrine (derivant of cruel propylhomoserin tyrosine), arachidonic acid etc. act on thermotaxic centre.
4, calm anticonvulsant action: succinic acid etc. have effects such as spasmolytic, epilepsy.
5, diuresis: succinic acid has diuresis.
6, collateral dredging effect: the successive dynasties book on Chinese herbal medicine is all on the books, the medicine commonly used of treatment arthromyodynia (arthritis).
7, kill smart effect: earth-worm extractive as raw material has sterilization functions to white mice and people's sperm.
8, excited uterus effect: earth-worm extractive as raw material can cause the hysterospasm contraction, so can be used as odinagogue.
9, antibiotic and antitumaous effect: earth-worm extractive as raw material has stronger antibacterial action to tubercule bacillus, and mice-transplanted tumor is had the obvious suppression effect.
10, anti-allergic effects: the Lumbricus nitrogen containing component has the irritated effect of antihistaminic.
11, functions of detoxifying and promoting tissue regeneration: no matter take orally and external, mucosa and skin ulcer are all had the healing of promotion effect.
12, thrombolytic, fibrinolytic and blood coagulation resisting function, Lumbrukinase, solubilized fibrin and activator of plasminogen effect.
13, other effect: the Lumbricus water extract has the effect of paralysis consciousness.Lumbricus also has the jaundice eliminating effect.
As can be seen above-mentioned, Lumbricus has wide biological activity, and developing Lumbricus medicinal is purpose of the present invention.
Summary of the invention
The object of the present invention is to provide the application of earth-worm extractive as raw material in preparation treatment female genital diseases medicine.
Another object of the present invention is to provide and contain above-mentioned earth-worm extractive as raw material at the pharmaceutical composition for the treatment of female genital inflammation.
A further object of the present invention is to extract the method that above-mentioned earth-worm extractive as raw material is used for the treatment of female genital inflammation.
The present invention relates to the application of earth-worm extractive as raw material at preparation treatment female genital inflammation, its Lumbricus is mainly the dry polypide of Pheretima aspergillum (Pheretgima aspergillum EPerrier1872) and the dark different lip earthworm of the back of the body (Allolobophora Caliginosa (Savigny) Trapezoides Aut, Duges, 1828).
Above-mentioned earth-worm extractive as raw material comprises compositions such as streptokinase, the acid protein of water solublity, aminoacid, PAF, oligopeptide, lumbricin, hypoxanthine, succinic acid, guanidine.
Through pharmacology and clinical confirmation, mucosa and skin ulcer all there is the healing of promotion effect.Antitumor action is arranged.To the urogenital tract infection patient, patients of cervical ruin especially, determined curative effect has functions of detoxifying and promoting tissue regeneration.Satisfactory effect.
The invention further relates to a kind of pharmaceutical composition for the treatment of female genital inflammation, the above-mentioned earth-worm extractive as raw material that wherein contains effective dose, earth-worm extractive as raw material of the present invention can be made various dosage forms according to prior art, wherein can contain acceptable carrier on the materia medica, excipient or other additives.As make suppository, effervescent, tablet, membrane, drop etc., but folk prescription or be made into compound recipe and use.
Above-mentioned earth-worm extractive as raw material, in the application of treatment female genital inflammation, when the outer time spent, effective dose is 0.1~5% of this extract.
The above-mentioned earth-worm extractive as raw material that the present invention relates in the treatment female genital inflammation is used, is mainly used in treatment cervical erosion, trichomonal vaginitis etc.
Adopt earth-worm extractive as raw material of the present invention, in treatment during female genital inflammation, curative effect is fast, curative effect is reliable, toxic and side effects is little, the cure rate height.
The invention still further relates to a kind of method of female genital inflammation, effective dose of the above-mentioned earth-worm extractive as raw material of external for the treatment of.
Best mode for carrying out the invention
Embodiment 1
1 part of earth-worm extractive as raw material is dissolved in 400 parts of 2% glycerites and Azone0.1~2%, makes solution become to contain 0.25% earth-worm extractive as raw material.
Embodiment 2
1 routine earth-worm extractive as raw material is dissolved in 200 parts of 2% glycerites and Azone0.1~2%, makes solution become to contain 0.5% earth-worm extractive as raw material.
Embodiment 3
1 part of earth-worm extractive as raw material is dissolved in 100 parts of 1%-2% glycerites and Azone0.1~2%, makes solution become to contain 1% earth-worm extractive as raw material.
Embodiment 4
1 part of earth-worm extractive as raw material is dissolved in 50 parts of 1%~2% glycerites and Azone0.1~2%, makes solution become to contain 2% earth-worm extractive as raw material.
Experimental example
Case 1-10:
Case 1-10 is the 24-35 women in year.10 examples are patients of cervical ruin.Year do not wait sick time half a year to 8, the treatment natural law did not wait in 3-12 days, and the treatment number of times does not wait for 3-10 time.Administering mode is external, and subjective symptoms and objective sign shape disappear.Details sees Table 1.
Model case one:
26 years old patients, the course of disease is suffered from slight cervical erosion more than a year.Behind the external secondary, recovery from illness.Once a day, use the next day.
Two of model case:
28 years old patients, the course of disease two and half is suffered from moderate cervical erosion.After the external five times, recovery from illness.Once a day, first three time logotype is used the next day of back twice.
Industrial applicability
The present invention to the invention of the new purposes of earth-worm extractive as raw material can with such extract for the preparation of Medicine and the pharmaceutical composition for the treatment of female genital inflammation.
Table 1 earth-worm extractive as raw material treatment cervical erosion
Case number | Age | The course of disease | Rotten to the corn calibration | The treatment number of times | The treatment fate | Curative effect |
1 2 3 4 5 6 7 8 9 10 | 24 24 26 27 27 28 30 32 32 35 | 1y 1.3y 6y 3y 4.4y 2y 4y 3y 6y 8y | I I I II + II + II II + II II + II + | 2 2 3 6 6 5 6 6 8 10 | 3 3 5 10 10 9 10 10 12 12 | Recovery from illness recovery from illness recovery from illness recovery from illness recovery from illness recovery from illness recovery from illness recovery from illness recovery from illness recovery from illness |
Claims (6)
1, the pharmaceutical composition of earth-worm extractive as raw material preparation is in the purposes of treatment female genital inflammation.
2, application according to claim 1, it is characterized by this extract is water extract and ethanol extract.
3, water extract according to claim 2 is characterized in that Lumbricus water extract Main Ingredients and Appearance is the acid protein of streptokinase, water solublity, mostly is oligopeptide etc. after the hydrolysis.
4, alcohol extract according to claim 2, the main component that it is characterized in that the Lumbricus alcohol extract is lumbricin, terrestro-lumbrolysin, hypoxanthine, succinic acid, aminoacid, plurality of enzymes etc.
5, application according to claim 1 is characterized in that the method that the pharmaceutical composition of this water extract and alcohol extract preparation is used for the treatment of female genital inflammation is external.
6, application according to claim 1, base are characterised in that the pharmaceutical composition effective dose of this water extract and alcohol extract treatment female genital inflammation is 0.25%~5% of an extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95110774A CN1135892A (en) | 1995-05-18 | 1995-05-18 | New use of Lumbricus extract for treating female genital tract inflammation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95110774A CN1135892A (en) | 1995-05-18 | 1995-05-18 | New use of Lumbricus extract for treating female genital tract inflammation |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1135892A true CN1135892A (en) | 1996-11-20 |
Family
ID=5078120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95110774A Pending CN1135892A (en) | 1995-05-18 | 1995-05-18 | New use of Lumbricus extract for treating female genital tract inflammation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1135892A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106890321A (en) * | 2015-12-18 | 2017-06-27 | 深圳瑞健生命科学研究院有限公司 | A kind of method for preventing and treating cervical erosion |
CN109331044A (en) * | 2018-11-20 | 2019-02-15 | 成都市农林科学院 | A kind of earth-worm extractive as raw material and preparation method thereof |
US10874721B2 (en) | 2015-12-18 | 2020-12-29 | Talengen International Limited | Method for preventing and treating cervical erosion |
US11007253B2 (en) | 2015-12-18 | 2021-05-18 | Talengen International Limited | Method for preventing or treating radiation and chemical damage |
-
1995
- 1995-05-18 CN CN95110774A patent/CN1135892A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106890321A (en) * | 2015-12-18 | 2017-06-27 | 深圳瑞健生命科学研究院有限公司 | A kind of method for preventing and treating cervical erosion |
US10874721B2 (en) | 2015-12-18 | 2020-12-29 | Talengen International Limited | Method for preventing and treating cervical erosion |
US11007253B2 (en) | 2015-12-18 | 2021-05-18 | Talengen International Limited | Method for preventing or treating radiation and chemical damage |
CN109331044A (en) * | 2018-11-20 | 2019-02-15 | 成都市农林科学院 | A kind of earth-worm extractive as raw material and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2362777B1 (en) | Use of pharmaceutical compositions in preparing pharmaceuticals for treating diabetic ulcer | |
CN1241578C (en) | Skin-care medicine with functions of relieving-itching, fully eliminating-toxins and curing-tinea, and its prepn. method | |
WO2022042541A1 (en) | Application of cobra venom or extract thereof in preparation of drugs for reducing uric acid and/or resisting gouty arthritis | |
CN1135892A (en) | New use of Lumbricus extract for treating female genital tract inflammation | |
CN1327832A (en) | Exterior-applied ointment for treating dermatitis | |
CN1733166A (en) | Chinese traditional medicine preparation for curing gastric ulcer | |
CN110623993A (en) | Compound nutritional tablet of traditional Chinese medicine composition for treating gynecological inflammation and preparation method thereof | |
CN1120721C (en) | Exterior-applied ointment for treating piles | |
CN101062082A (en) | Arthralgia treating medical composition | |
CN1989990A (en) | Medicine for treating erection dysfunction and preparation method thereof | |
CN1943778A (en) | The mixture of cobra venom and Chinese medical herb extract and its application | |
CN1288379A (en) | Method and kits for treating vulvovaginal candidiasis with micronazole nitrate | |
CN106880654B (en) | Application of panax japonicus extract in preparing medicine for treating rhinitis and composition | |
CN1171622C (en) | Medicine for treating skin disease and its preparing method | |
CN1111051C (en) | Medicine for treating cough and asthma | |
CN1490043A (en) | Medicine for resolving sputum and relieving asthma and cough, preparing process thereof | |
CN116115680B (en) | External traditional Chinese medicine composition for promoting healing as well as preparation and application thereof | |
He et al. | Progress in research on mechanism of saponins in treating osteoarthritis | |
CN1947719A (en) | Application of aspirin for preventing and treating osteoporosis | |
CN1165331C (en) | Chinese medicine for treating tuberculosis | |
CN116763772A (en) | Application of homoplantagin in preparation of anti-rosacea inflammatory reaction medicine | |
CN1273167C (en) | Medicine for external application for curing rheumatism and its preparation method | |
CN105233266A (en) | Spray for promoting wound healing | |
CN1232286C (en) | Medication for treating hemorrhoids and preparation method | |
CN118255663A (en) | Extraction method and application of 3, 4-dihydroxymethyl benzoate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |